Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Gynecol Oncol. 2018 Oct 24;151(3):407–413. doi: 10.1016/j.ygyno.2018.10.008

Table 3.

Description of Severe (Grade 3 or 4) Adverse Events

Frequency (number of events, %)
Total patients: 44, Total events: 28
Grade 3/4 Adverse Events
    Neurologic 2 (4.6)
    Cardiovascular 2 (4.6)
    Pulmonary 3 (6.8)
    Endocrine 0 (0)
    Hepatic 6 (13.6)
    Pancreatic 6 (13.6)
    Colitis 2 (4.6)
    Hematologic 5 (11.4)
    Dermatologic 2 (4.6)